KRAS G12D inhibitor 9
KRAS G12D inhibitor 9 is a potent inhibitor of KRAS G12D. The Ras family of proteins is an important intracellular signaling molecule that plays an important role in growth and development. KRAS G12D inhibitor 9 has the potential for the research of KRAS G12D-mediated cancer (extracted from patent WO2021108683A1, compound 20) [1].
Product Specifications
CAS Number
2648551-39-5
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12d-inhibitor-9.html
Solubility
10 mM in DMSO
Smiles
CN(CCC1)[C@@H]1COC2=NC(N3CCC(CC3)N=C=NCCOC)=C4C(CN(C5=CC=CC6=C5C(C)=CC=C6)CC4)=N2
Molecular Formula
C33H43N7O2
Molecular Weight
569.74
References & Citations
[1]Jennifer PITZEN, et al. Covalent ras inhibitors and uses thereof. Patent WO2021108683A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD10 (CB-CALLA), CF640R conjugate, 0.1mg/mL
